title: Thalidomide therapy for low-risk Myelodysplasia.
authors.forename: David
authors.initials: D
authors.lastname: Bowen
authors.forename: Louisa
authors.initials: L
authors.lastname: MacIlwaine
authors.forename: Jamie
authors.initials: J
authors.lastname: Cavanagh
authors.forename: Sally
authors.initials: S
authors.lastname: Killick
authors.forename: Dominic
authors.initials: D
authors.lastname: Culligan
authors.forename: Ewan
authors.initials: E
authors.lastname: Thomson
authors.forename: Ghulam
authors.initials: G
authors.lastname: Mufti
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012306:Risk; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide